Atramist-25

Atramist-25

Hydroxyzine HCl 25 mg

25 mg

Indications

  • Short-term management of generalised anxiety disorder and tension states
  • Pruritus associated with urticaria, atopic dermatitis, and contact dermatitis
  • Pre-operative and pre-procedural anxiolysis and sedation
  • Adjunct in alcohol withdrawal for anxiety and agitation

Contraindications

  • Known hypersensitivity to Hydroxyzine, Cetirizine, or piperazine derivatives
  • Prolonged QT interval or congenital QTc prolongation — Hydroxyzine prolongs QT
  • Pregnancy (especially first trimester) — neonatal effects reported; avoid in breast-feeding

Side effects

  • Sedation and drowsiness — caution when driving or operating machinery
  • Dry mouth, urinary retention, and constipation (anticholinergic effects)
  • QT prolongation at high doses — ECG monitoring in at-risk patients

Important: This information is provided for educational purposes only and is not a substitute for professional medical advice. Please consult a Registered Medical Practitioner before starting, stopping, or changing any medication. Manufactured and marketed under Indian DCGI regulations.

Related Products

More from the same therapeutic area.